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Abstract
Background: No molecular data have been available on tick-borne pathogens that infect dogs from Angola. The
occurrence of agents from the genera Anaplasma, Babesia, Ehrlichia and Hepatozoon was assessed in 103 domestic
dogs from Luanda, by means of the polymerase chain reaction (PCR) and DNA sequence analysis.
Results: Forty-six dogs (44.7 %) were positive for at least one pathogen. Twenty-one animals (20.4 %) were found
infected with Anaplasma platys, 18 (17.5 %) with Hepatozoon canis, six (5.8 %) with Ehrlichia canis, six (5.8 %) with
Babesia vogeli, one (1.0 %) with Babesia gibsoni and one (1.0 %) with an unnamed Babesia sp. The molecular frequency
of single infections taken together was 37.9 % and that of co-infections with several combinations of two pathogens
accounted for 6.8 % of the animals.
Conclusions: This is the first report of A. platys, B. vogeli, B. gibsoni, E. canis and H. canis infections diagnosed by PCR in
domestic dogs from Angola. The present study provides evidence that dogs in Luanda are widely exposed to, and at
risk of becoming infected with, tick-borne pathogens. Further investigation is needed, including a larger number of
animals, canine populations from other cities and provinces of the country, as well as potential vector ticks, aiming at
better characterizing and controlling canine vector-borne diseases in Angola.
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Background
Angola is located in an area termed Middle Africa
(United Nations geographic subregion). The country’s
human population is slightly above 20 million, with a
quarter living in the capital city of Luanda, which has a
mild semi-arid climate, warm to hot and dry. The size of
the canine population was estimated to be 480,000 at
the country level in the year 2013, with a density of 0.39
dogs per square kilometer [1]. The number of dogs in
Luanda has not been determined and they range from
house-kept pets to free-roaming and stray animals.
Information on canine vector-borne disease (CVBD)
agents at the local and regional levels allows veterinar-
ians to better recognize the pathogens that can affect
dogs, thus facilitating diagnosis and treatment [2, 3]. To
date, no molecular data have been available on the
prevalence or even the occurrence of tick-borne patho-
gens in dogs from Luanda, Angola. The hypothesis
under testing in the current study was that owned dogs
in Luanda are infected with a large number of different




One hundred and three pet dogs presented to a veterin-
ary clinic in the city of Luanda, Angola, were sampled
during January and February 2013. The age of dogs
ranged from 3 to 168 months (median: 12 months; inter-
quartile range: 7.3–48); and there were 61 males and 42
females. Owners provided their informed consent for
inclusion of their animals in the study, which had been
approved by the scientific council of Escola Universitária
Vasco da Gama as complying with the Portuguese
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legislation for the protection of animals (Law no. 92/
1995 and Decree-Law no. 113/2013).
Forty-nine apparently healthy dogs were presented
for prophylactic procedures, including vaccination and
deworming, or for elective surgery; 54 dogs clinically
suspected of a CVBD had anorexia, weight loss, fever, de-
hydration, onychogryphosis, lymphadenomegaly, gastro-
intestinal alterations, jaundice, dermatological or ocular
abnormalities, anemia, thrombocytopenia, leukocytosis or
leukopenia, hyperproteinemia, and hyperglobulinemia.
Sixty-two dogs had detectable ticks.
Blood was collected in EDTA and centrifuged, with
two thirds of the plasma volume separated from cells,
and the remaining plasma frozen together with cells at
-20 °C. DNA was extracted from the concentrated blood
samples using a commercial kit (E.Z.N.A.® Blood DNA
Mini Kit, Omega Bio-Tek, Norcross, GA, USA), accord-
ing to the manufacturer’s instructions.
DNA amplification and sequencing
The detection of Ehrlichia and Anaplasma species was
performed by screening all DNA samples first by a real
time PCR assay targeting a 123 bp fragment of 16S
rRNA gene (E.c 16S-fwd/E.c 16S-rev [4]). Positive sam-
ples were tested by a second conventional nested-PCR
using the ECC and ECB primers targeting a 500 bp frag-
ment of the 16S rRNA gene in the first round of PCR
followed by a second round of PCR using E. canis-spe-
cific primers (Ecan/HE3 [5]) and A. platys-specific
primers (ApysF/ApysR [5]) (Table 1). DNA extracted
from an E. canis cell culture and DNA extracted from a
dog infected with A. platys confirmed by PCR and
sequencing were used as positive controls.
Molecular detection of Babesia and Hepatozoon spe-
cies was performed by screening all DNA samples by a
conventional PCR assay targeting a 400 bp fragment of
the 18S rRNA gene (Piroplasmid-F/Piroplasmid-R [6]).
In order to identify cases of co-infection, positive
samples were tested by additional PCRs using primers
specifically designed for the detection of a fragment of
the18S rRNA gene of Babesia spp. (Babesia18S-F/Babe-
sia18S-R [7]) and Hepatozoon spp. (Hepatozoon18S-F/
Hepatozoon18S-R [7]) (Table 1). DNA extracted from a
dog infected with H. canis and from another dog in-
fected with B. vogeli confirmed by PCR and sequencing
were used as positive controls.
Conventional PCR was performed in a total volume of
25 μl using the PCR-ready High Specificity mix (Syntezza
Bioscience, Jerusalem, Israel) with 500 nM of each
primers and sterile DNase/RNase-free water (Sigma,
St. Louis, MO, USA). Amplification was performed
using a programmable conventional thermocycler
(Biometra, Göttingen, Germany). Initial denaturation
at 95 °C for 5 min, was followed by 35 cycles of de-
naturation at 95 °C for 30 s, annealing and extension
at 65 °C for 30 s (for ECC/ECB), 62 °C for 30 s (for
ApysF/ApysR), 64 °C for 30 s (for Piroplasmid-F/Piro-
plasmid-R), 58 °C for 30 s (for Babesia18S-F/Babe-
sia18S-R), 50 °C for 30 s (for Hepatozoon18S-F/
Hepatozoon18S-R) and 10 cycles of 62 °C for 30 s
followed by 25 cycles of 60 °C for 30 s for the
ECAN5/HE3 primers, and final extension at 72 °C for
30 s. After the last cycle, the extension step was con-
tinued for a further 5 min. PCR products were elec-
trophoresed on 1.5 % agarose gels stained with
ethidium bromide and evaluated under UV light for
the size of amplified fragments by comparison to a
100 bp DNA molecular weight marker.
Real time PCR was performed in a total volume of
20 μl containing 5 μl DNA, 400 nM of each primer,
10 μl Maxima Hot Start PCR Master Mix (2×) (Thermo
Scientific, Epsom, Surrey, UK), 50 μM of SYTO9
Table 1 Targeted organisms and list of primers used in this study
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solution (Invitrogen, Carlsbad, CA, USA) and sterile
DNase/RNase-free water (Sigma, St. Louis, MO, USA),
using the StepOnePlus real-time PCR thermal cycler
(Applied Biosystems, Foster City, CA, USA). Initial de-
naturation for 5 min at 95 °C was followed by 40 cycles
of denaturation at 95 °C for 5 s, annealing and extension
at 59 °C for 30 s, and final extension at 72 °C for 20 s.
Amplicons were subsequently subjected to a melt step
with the temperature raised to 95 °C for 10 s and then
lowered to 60 °C for 1 min. The temperature was then
raised to 95 °C at a rate of 0.3 °C per second. Amplifica-
tion and melt profiles were analyzed using the StepOne-
Plus software v2.2.2 (Applied Biosystems, Foster City,
CA, USA).
Negative uninfected dog DNA, and non-template
DNA controls were used in each run for all pathogens.
Positive PCR products were sequenced using the Big-
Dye Terminator v3.1 Cycle Sequencing Kit and an ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA), at the Center for Genomic
Technologies, Hebrew University of Jerusalem, Israel.
DNA sequences were evaluated with the ChromasPro
software version 2.1.1 (Technelysium Pty Ltd., South
Brisbane, QLD, Australia) and compared for similarity
with sequences available in GenBank®, using the BLAST
program (http://www.ncbi.nlm.nih.gov/BLAST/). The
species identity found was determined according to the
closest BLAST match with an identity of 97–100 %
[8–10] to an existing GenBank® accession (Table 2).
Data analysis
Exact binomial 95 % confidence intervals (CI) were
established for proportions. Analyses were done using
the StatLib.
Results and discussion
Out of the 103 dogs, 21 (20.4 %; CI: 13.1–29.5 %) were
found infected with A. platys, 18 (17.5 %; CI: 10.7–26.2)
with H. canis, six (5.8 %; CI: 2.2–12.2) with E. canis, six
(5.8 %; CI: 2.2–12.2) with B. vogeli, one (1.0 %; CI: 0.0–
Table 2 Vector-borne pathogens from the 46 positive dogs and their similarity with sequences deposited in GenBank®
Primers Closest GenBank® accession Identity (no. of dogs) Pathogen Dog’s code New GenBank accessions
ECB/ECC + KP844663 97–99 % (5) Ehrlichia canis L-002 KX082900
ECAN5/HE3 KP662546 100 % (1) L-009 KX082901
ECB/ECC +
ApysF/ApysR
KT357373 100 % (19) Anaplasma platys L-001 KX082895
KP903295 99 % (1) L-015 KX082896





KP864658 99 % (5) Babesia vogeli L-018 KX082915
L-019 KX082916
L-024 KX082917
LC012801 97 % (1) Babesia gibsoni L-036 KX082918
KJ956782 97 % (1) Babesia sp. L-084 KX082919
KJ868816 99–100 % (10) Hepatozoon canis L-008 KX082910
DQ439540 99–100 % (2) L-021 KX082911
KP216462 100 % (1) L-032 KX082912
KT587790 100 % (1) L-041 KX082913
KP216425 99 % (1) L-105 KX082914
KC138532 97 % (1)
Babesia18S-F/
Babesia18S-R
KJ494656 99–100 % (4) B. vogeli L-018 KX082902




KP715302 98–99 % (12) H. canis L-008 KX082905
DQ439540 99 % (1) L-021 KX082906
KP182934 99 % (1) L-032 KX082907
KP715303 99 % (1) L-041 KX082908
L-105 KX082909
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5.3) with B. gibsoni and another one (1.0 %; CI: 0.0–5.3)
with an unnamed Babesia sp. (Table 3). Forty-six dogs
(44.7 %; CI: 34.9–54.8) were found infected with at least
one of the detected pathogens; and seven dogs (6.8 %,
CI: 2.8–13.5) were found co-infected with two of the
pathogens (Table 3). Table 2 displays the identification
of canine vector-borne pathogens according to the simi-
larity of their amplified sequences with those available in
GenBank®.
To the best of our knowledge, this is the first report of
A. platys, B. vogeli, B. gibsoni, E. canis and H. canis in
dogs from Angola. The results of this study provide evi-
dence for the presence of up to five distinct tick-borne
pathogens among the canine population from the city of
Luanda, which had previously not been molecularly doc-
umented, with A. platys and H. canis being the most
prevalent. At least one tick-borne agent was detected in
around 45 % of the dogs examined and, although expos-
ure can vary according to the different pathogens, pet
dogs are at a moderate to high risk of being infected
with vector-borne agents at the local level.
All the canine pathogens detected in the present study
at the species level share Rhipicephalus sanguineus
(sensu lato) [11] ticks as their exclusive, possible or pre-
sumed vector. The fact that A. platys and H. canis were
more frequently found than Babesia spp. and E. canis in
dogs from Luanda might be related to the hypothesis
that the local tick vector populations more frequently
harbour some specific agents than others [12]. On the
other hand, infections with more virulent agents, such
as E. canis and Babesia spp., are less likely to have high
frequencies due to the fact that hosts more often
succumb to disease or are treated against it, with patho-
gen circulation thus being decreased [13]. The high fre-
quency of A. platys and H. canis should be brought to
the attention of veterinarians and dog owners in order
to decrease the burden of the diseases those agents can
cause in dogs. Detection and identification of pathogen
species, either in single or in co-infection, are necessary
for the treatment and prevention of CVBDs [2].
Ticks have not been identified in the scope of the
present study, but it is presumed that some or even all
of them could be R. sanguineus (s.l.). Indeed, these are
the most widespread ticks in the world, being most
abundant in temperate, subtropical and tropical climate
regions [11]. Anaplasma platys, B. vogeli, B. gibsoni, Ba-
besia sp., E. canis and H. canis were found in dogs with
clinical signs compatible with a CVBD and may have
contributed to causing them. Still, A. platys, B. vogeli, E.
canis and H. canis were also found in dogs not clinically
suspect of a CVBD, thus revealing subclinical infections.
All the agents could be found in dogs that had not
travelled outside of the Luanda province. This fact
suggests that these infections were locally acquired and,
together with the diseases they cause, are endemic in the
area of Luanda. Rather than having recently emerged,
some of these infections have locally existed, as sug-
gested by microscopic observation of Giemsa-stained
blood smears and rapid serological tests (unpublished
observations provide names of those who made these
observations), but this is their first detection and con-
firmation at the molecular level.
In the present study, one dog was found infected with
B. gibsoni. This animal was a clinically suspect one-year
old Pit Bull-type male dog, with short hair length and no
detectable ticks, that had received ectoparasiticides, lived
outdoors and had not travelled to outside of the Luanda
province. In the USA [14–16] and Australia [17], B. gib-
soni infection has been found mostly in Pit Bull Terrier
dogs. Indeed, studies in these countries indicate that dir-
ect dog-to-dog transmission is highly likely through bites
and might even be the main mode of transmission
among fighting dog breeds [15, 17]. In the present study,
there were six other Pit Bull-type dogs and four of them
were found infected with at least one CVBD agent, i.e.
one with A. platys, another one with B. vogeli and two
with H. canis.
The samples tested in the present study were collected
in a veterinary medical centre from client-owned dogs.
This circumstance could have biased the inclusion of a
greater number of animals clinically suspect of a CVBD
(n = 54; 52.4 %) compared with a lower proportion they
may represent in the general canine population of
Luanda and Angola. The frequency of infection with
each pathogen should be regarded as an average value,
taking also into account that the sampled dogs were
Table 3 Single and co-infections with vector-borne pathogens




Single infections 39 37.9 28.5–48.0
Anaplasma platys 16 15.5 9.2–24.0
Babesia gibsoni 1 1.0 0.0–5.3
Babesia vogeli 3 2.9 0.6–8.3
Babesia sp. 1 1.0 0.0–5.3
Ehrlichia canis 5 4.9 1.6–11.0
Hepatozoon canis 13 12.6 6.9–20.6
Co-infections 7 6.8 2.8–13.5
A. platys + B. vogeli 1 1.0 0.0–5.3
A. platys + H. canis 4 3.9 1.1–9.6
B. vogeli + E. canis 1 1.0 0.0–5.3
B. vogeli + H. canis 1 1.0 0.0–5.3
Single + co-infections (≥ 1 agent) 46 44.7 34.9–54.8
CI, 95 % confidence interval
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well-cared for and may have not represented the overall
canine population both at the national and city levels.
Due to these facts, the prevalence of tick-borne agents
in the overall populations of dogs from Angola and from
the Luanda province and city might be higher [18].
This preliminary and geographically localized sample
may have also limited the detection of a wider variety of
tick-borne and other vector-borne pathogens. For ex-
ample, B. rossi, which was not detected in this study, is
known to be endemic in South Africa [13], Sudan [19],
Nigeria [20] and Uganda [21]. In addition, the agent of
human monocytic ehrlichiosis, Ehrlichia chaffeensis, was
previously detected in dogs from Uganda [21] and in
ticks collected from dogs in Cameroon [22]; and the
agent of human granulocytic ehrlichiosis, Ehrlichia ewin-
gii, was detected in dogs from Cameroon [23]. The spe-
cies Babesia canis (sensu stricto), which is prevalent in
Europe, where it is vectored by tick Dermacentor reticu-
latus, was found in a dog from Nigeria [24]. In the
present study, a dog found infected with A. platys and
H. canis had also been found PCR-positive and seroposi-
tive for Leishmania infantum and clinically affected by
leishmaniosis. The frequency of canine Leishmania in-
fection in the studied population was apparently low (i.e.
1.0 % by PCR and 1.9 % by serological direct agglutin-
ation test) [25].
Prevention of CVBDs largely relies on ectoparasite
control [26], with the regular or long-lasting application
of effective anti-vector products on individual dogs
remaining the best approach to control infestations and
associated diseases [27]. Prevention of H. canis infection
should, in addition, rely on avoidance of ingestion of
ticks. Most tick-borne pathogens of dogs, such as
Anaplasma spp., Babesia spp. and Ehrlichia spp., are
transmittable through blood product transfusions and
infection with those pathogens should be screened in
canine blood donors on a regular basis [28].
Conclusions
In conclusion, the present study provides evidence that
dogs in Luanda are widely exposed to and at high risk of
becoming infected with tick-borne pathogens. This is
the first report of A. platys, B. vogeli, B. gibsoni, E. canis
and H. canis molecular detection and characterization in
domestic dogs from Angola. Veterinarians as well as pet
owners will benefit from being aware of the confirmed
existence of these CVBD agents, in order to better
diagnose, treat and prevent infections and their related
diseases in dogs. Further investigation, including a larger
number of dogs, canine populations from other cities
and provinces of Angola, as well as potential vector
ticks, is needed to better characterize CVBDs in the
country.
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